NEW YORK, Dec. 8 Reportlinker.com announces that a new market research report is available in its catalogue:
European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
Advertisement
http://www.reportlinker.com/p0166835/European-Markets-for-Drug-Eluting-and-Bare-Metal-Stents-2009-15-Countries.html
The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stents and bare-metal stents.
Advertisement
TABLE OF CONTENTS
EUROPEAN MARKETS FOR DRUG-ELUTING AND BARE METAL STENTS 2009
(15 COUNTRIES) .......I
TABLE OF CONTENTS .................... II
LIST OF FIGURES ...V
LIST OF CHARTS VII
RESEARCH METHODOLOGY ........ 9
1.1 RESEARCH SCOPE ........................ 9
1.2 IDATA'S 9-STEP METHODOLOGY 9
Step 1: Project Initiation & Team Selection ......... 10
Step 2: Prepare Data Systems and Perform Secondary Research ... 11
Step 3: Preparation for Interviews & Questionnaire Design .......... 12
Step 4: Performing Primary Research .................. 13
Step 5: Research Analysis: Establishing Baseline Estimates .......... 15
Step 6: Market Forecast and Analysis .................. 15
Step 7: Identify Strategic Opportunities ............... 17
Step 8: Final Review and Market Release ............ 18
Step 9: Customer Feedback and Market Monitoring ....................... 19
EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES....... 20
2.1 INTRODUCTION . 20
2.2 CURRENCY EXCHANGE RATES .. 21
2.3 EFFECTS OF THE ECONOMIC CRISIS ...................... 22
2.4 OVERVIEW OF THE MARKET ...... 23
2.4.1 Market Segmentation by Device Type ............. 26
2.4.2 Market Segmentation by Country ................... 33
2.4.2.1 Germany 33
2.4.2.2 France ..33
2.4.2.3 Italy ......33
2.4.2.4 Spain ....34
2.4.2.5 United Kingdom ..............34
2.4.2.6 Benelux 34
2.5 TREND ANALYSIS BY COUNTRY 38
2.6 MARKET DRIVERS ..................... 41
2.7 MARKET LIMITERS .................... 42
2.8 COMPETITIVE ANALYSIS ........... 43
2.9 MERGERS AND ACQUISITIONS ... 48
COUNTRY PROFILES ..................... 51
3.1 INTRODUCTION . 51
3.1.1 Population . 51
3.1.2 GDP per Capita ................... 51
3.1.3 PCI and DES Penetration Rates ..................... 51
3.1.4 Price Index 52
3.2 GERMANY ....... 53
3.3 FRANCE ........... 54
3.4 UNITED KINGDOM ..................... 55
3.5 ITALY .............. 56
3.6 SPAIN .............. 57
3.7 BENELUX ........ 58
3.8 SCANDINAVIA . 59
3.9 PORTUGAL ...... 60
3.10 AUSTRIA ....... 61
3.11 SWITZERLAND . 62
BARE-METAL AND DRUG-ELUTING STENTS .... 63
4.1 INTRODUCTION . 63
4.2 OVERVIEW OF THE MARKET ...... 65
4.2.1 Total Coronary Stent Market . 65
4.2.2 Bare-Metal versus Drug-Eluting Stents .......... 70
4.3 MARKET ANALYSIS AND FORECAST .................... 73
4.3.1 Bare-Metal Stent Market ..... 73
4.3.1.1 Market Analysis and Forecast ...................73
4.3.1.2 Bare-Metal Stent Market Drivers ..............78
4.3.1.3 Bare-Metal Stent Market Limiters .............78
4.3.1.4 Bare-Metal Stent Competitive Analysis .....80
4.3.2 Drug-Eluting Stent Market .. 83
4.3.2.1 Market Analysis and Forecast ...................83
4.3.2.2 Drug-Eluting Stent Market Drivers ...........87
4.3.2.3 Drug-Eluting Stent Market Limiters ..........87
4.3.2.4 Drug-Eluting Stent Competitive Analysis ..90
4.3.3 Stents in Development .......... 94
4.3.3.1 Bioabsorbable Stents ......95
4.3.3.2 Bifurcated Stents .............98
ABBREVIATIONS 101
LIST OF FIGURES
RESEARCH METHODOLOGY ...................... 9
EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES.... 20
Figure 3-1: Exchange Rates for the Euro (euro), 2008 ................... 21
Figure 3-2: Market for Interventional Cardiology, Europe, 2005 - 2015 .............. 24
Figure 3-3: Market for Interventional Cardiology, Segmented by Device Type,
Europe, 2005 - 2015 (euro) . 28
Figure 3-4: Market for Interventional Cardiology, Segmented by Device Type,
Europe, 2005 - 2015 (US$) ...................... 31
Figure 3-5: Market for Interventional Cardiology, Segmented by Country,
Europe, 2005 - 2015 (euro) . 36
Figure 3-6: Market for Interventional Cardiology, Segmented by Country,
Europe, 2005 - 2015 (US$) ...................... 37
Figure 3-7: Interventional Cardiology Market Growth Rates by Country, Europe,
2005 - 2015 .................. 39
Figure 3-8: Market Drivers, European Market for Interventional Cardiology, 200841
Figure 3-9: Market Limiters, European Market for Interventional Cardiology,
2008 .. 42
Figure 3-10: Leading Competitors, Market for Interventional Cardiology, Europe,
2008 .. 44
Figure 3-11: Leading Competitors, Market for Interventional Cardiology by
Country, Europe, 2008 (Part 1) ................ 46
COUNTRY PROFILES ..... 51
Figure 5-1: Country Indicators, 2008 ............ 52
BARE-METAL AND DRUG-ELUTING STENTS .................... 63
Figure 6-1: Market for Coronary Stents by Type, Europe, 2005 - 2015 (euro) .......... 66
Figure 6-2: Market for Coronary Stents by Type, Europe, 2005 - 2015 (US$)...... 66
Figure 6-3: Market for Coronary Stents by Country, Europe, 2005 - 2015 (euro)...... 68
Figure 6-4: Market for Coronary Stents by Country, Europe, 2005 - 2015 (US$) . 69
Figure 6-5: Penetration Rate for Coronary Stents by Type, Units Sold, Europe,
2005 - 2015 .................. 70
Figure 6-6: DES Penetration by Country, Europe, 2005 - 2015 71
Figure 6-7: Market for Bare-Metal Stents by Country, Europe, 2005 - 2015 (euro)... 75
Figure 6-8: Market for Bare-Metal Stents by Country, Europe, 2005 - 2015 (US$)76
Figure 6-9: Market Drivers and Limiters, Market for Bare-Metal Stents, Europe,
2008 .. 79
Figure 6-10: Leading Competitors, Market for Bare-Metal Stents, Europe, 2008.. 81
Figure 6-11: Market for Drug-Eluting Stents by Country, Europe, 2005 - 2015 (euro)84
Figure 6-12: Market for Drug-Eluting Stents by Country, Europe, 2005 - 2015
(US$) 85
Figure 6-13: Market Drivers and Limiters, Market for Drug-Eluting Stents,
Europe, 2008 ................ 89
Figure 6-14: Leading Competitors, Market for Drug-Eluting Stents, Europe, 200892
Figure 6-15: Coronary Stent Platforms in Development, 2008 .. 94
Figure 6-16: Potential Market for Bioabsorbable Stents, Europe, 2010 - 2015 (euro) 96
Figure 6-17: Potential Market for Bioabsorbable Stents, Europe, 2010 - 2015
(US$) 96
Figure 6-18: Potential Market for Bifurcated Stents, Europe, 2010 - 2015 (euro) ..... 99
Figure 6-19: Potential Market for Bifurcated Stents, Europe, 2010 - 2015 (US$) . 99
ABBREVIATIONS ......... 101
LIST OF CHART S
RESEARCH METHODOLOGY ...................... 9
EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES.... 20
Chart 3-1: Market for Interventional Cardiology, Europe, 2005 - 2015 (euro) .......... 25
Chart 3-2: Market for Interventional Cardiology, Segmented by Device Type,
Europe, 2008 ................ 30
Chart 3-3: Fastest Growing Interventional Cardiology Markets by Country,
Europe, 2005 - 2015 ..... 40
Chart 3-4: Leading Competitors, Market for Interventional Cardiology, Europe,
2008 .. 45
COUNTRY PROFILES ..... 51
Chart 5-1: German Price Index, DES Penetration, Population, GDP per Capita,
and PCI Penetration Rate, 2008 ................ 53
Chart 5-2: French Price Index, DES Penetration, Population, GDP per Capita,
and PCI Penetration Rate, 2008 ................ 54
Chart 5-3: The U.K. Price Index, DES Penetration, Population, GDP per Capita,
and PCI Penetration Rate, 2008 ................ 55
Chart 5-4: Italian Price Index, DES Penetration, Population, GDP per Capita, and
PCI Penetration Rate, 2008 ...................... 56
Chart 5-5: Spanish Price Index, DES Penetration, Population, GDP per Capita,
and PCI Penetration Rate, 2008 ................ 57
Chart 5-6: Beneluxian Price Index, DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2008 .... 58
Chart 5-7: Scandinavian Price Index, DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2008 .... 59
Chart 5-8: Portuguese Price Index, DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2008 .... 60
Chart 5-9: Austrian Price Index, DES Penetration, Population, GDP per Capita,
and PCI Penetration Rate, 2008 ................ 61
Chart 5-10: Swiss Price Index, DES Penetration, Population, GDP per Capita,
and PCI Penetration Rate, 2008 ................ 62
BARE-METAL AND DRUG-ELUTING STENTS .................... 63
Chart 6-1: Market for Coronary Stents by Type, Europe, 2005 - 2015 (euro)............ 67
Chart 6-2: Penetration Rate for Coronary Stents by Type, Units Sold, Europe,
2005 - 2015 .................. 72
Chart 6-3: Market for Bare-Metal Stents, Europe, 2005 - 2015 (euro) ...................... 77
Chart 6-4: Leading Competitors, Market for Bare-Metal Stents, Europe, 2008 ..... 82
Chart 6-5: Market for Drug-Eluting Stents, Europe, 2005 - 2015 (euro) ................... 86
Chart 6-6: Leading Competitors, Market for Drug-Eluting Stents, Europe, 2008 .. 93
Chart 6-7: Penetration Rate for Bioabsorbable Stents, Europe, 2010 - 2015......... 97
Chart 6-8: Penetration Rate for Bifurcated Stents, Europe, 2010 - 2015 ............ 100
ABBREVIATIONS ......... 101
To order this report:
Cardiovascular Devices Industry: European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
More Market Research Report
Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
